Cosyntropin vs Capromorelin
Head-to-head comparison of Cosyntropin (Cosyntropin (ACTH 1-24)) and Capromorelin (Capromorelin hydrochloride) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Cosyntropin | Capromorelin |
|---|---|---|
| Category | Pain Management | Growth Hormone |
| Full Name | Cosyntropin (ACTH 1-24) | Capromorelin hydrochloride |
| Molecular Weight | 2933.3 Da | N/A |
| Half-Life | ~10 min | about 2-3 hours |
| Amino Acids | 24 | N/A |
| Typical Dose | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary | 0.25-2 mg/kg/day |
| Route | IV|IM | Oral |
| Purity | ≥98% | ≥98% |
| Studies Count | 61 | 55 |
| Research Status | Clinical research | Clinical |
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
Capromorelin Benefits
- ✓GH secretagogue activity
- ✓appetite stimulation
- ✓oral administration
- ✓translational animal model utility
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
Capromorelin Dosing
0.25-2 mg/kg orally in studies|once-daily or protocol-specific dosing|monitor appetite and body weight
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
Capromorelin Side Effects
- ⚠increased appetite
- ⚠vomiting or nausea
- ⚠lethargy
Research Overview
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
Capromorelin
Research consistently shows capromorelin activates the ghrelin receptor pathway and increases food intake. Human development has been less prominent than veterinary use, but the compound remains a relevant GH secretagogue prototype.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.